Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination

Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.

¹ Division of Hematology, New York Presbyterian Hospital - Weill Cornell, New York, New York.
² Division of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
³ Division of Hematology, University of Washington, Seattle, Washington.
⁴ Division of Hematology/Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington, District of Columbia.
⁵ Centre Hospitalier Universitaire Henri-Mondor, Université Paris Est Creteil, Creteil, France.
⁶ The Bleeding and Clotting Disorders Institute, University of Illinois College of Medicine-Peoria, Peoria, Illinois.
⁷ Division of Hematology and Transfusion Medicine, Lund University, Lund, Sweden.
⁸ Department of Medicine, Michael G. DeGroote School of Medicine, McMaster Centre for Transfusion Research, McMaster University, Hamilton, Ontario, Canada.
⁹ Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
¹⁰ Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
¹¹ Division of Pediatric Hematology/Oncology, New York Presbyterian Hospital - Weill Cornell, New York, New York.

No abstract available

MeSH terms